Cell Cryopreservation Market To Reach $35.03 Billion By 2030

Cell Cryopreservation Market Growth & Trends

The global cell cryopreservation market size is expected to reach USD 35.03 billion by 2030 with a CAGR of 21.01%, according to a new report by Grand View Research, Inc. The increased use of ready-to-freeze media, combined with rising infertility rates, is driving demand for these products. Furthermore, the rising prevalence of chronic diseases, as well as the increasing importance of cell therapy for disease management, have prompted the demand for effective cryopreservation.

The increased demand for cost-effective cryopreservation medium has stemmed from increased research & development (R&D) activities to create advanced medicines. The capacity of ready-to-use media to decrease the development of ice crystals while cryopreserving live cells led to its increasing adoption among the research community. Furthermore, the rising popularity of cell-based drugs has resulted in massive investments from manufacturers to develop sophisticated biopharmaceuticals for serious medical conditions, which will propel the demand for cryopreservation and further boost the market growth.

The rapid R&D for the COVID-19 vaccine, as well as its continued commercial manufacturing activities, have also significantly impacted and stimulated biologics-based research activities, resulting in increased market growth. Furthermore, the growing market demand, increased competition among competitors, and diverse applications by end-users have all contributed to developments in cryopreservation freezing media formulations, which are now even accessible on a custom basis. For example, Merck KGaA's Sigma Aldrich brand provides frozen media solutions for stem cell applications while ensuring optimal recovery and cell survival, thus, propelling the cryopreservation market growth.

The versatility, ready-to-use, and inexpensive cost of these media over traditional freezing processes have resulted in widespread adoption among end-users. Traditional freezing processes necessitate the use of liquid nitrogen, which has significant safety concerns. Other disadvantages of nitrogen use include the potential of cross-contamination, high operating costs, and the risk of asphyxiation due to the displacement of atmospheric oxygen. As a result, the use of ready-to-use freezing media has grown in recent years which further boosts the cryopreservation market.

Additionally, developments in freezing media formulation and cryopreservation techniques, as well as leveraging cryopreservation freezing media applications in fields such as tissue engineering, cellular treatment, and stem cell research, have driven the market at a substantial rate. Favorable government regulations for regenerative medicine & cell-based research are expected to further boost the global market.

 Request a free sample copy or view report summary: Cell Cryopreservation Market Report

Cell Cryopreservation Market Report Highlights

• Based on product, the consumables segment accounted for the largest market share of 40.76% in 2023. The market is expanding due to the growing demand for cell based-therapies & preservation, and re-purchasing of consumables by end-users

• Based on application, stem cells accounted for the largest market share of 35.80% in 2023. Increased stem cell research and the development of advanced therapies by medical professionals and scientists is predicted to drive the market growth

• North America held the largest market share of 40.26% in 2023. This is mostly due to the presence of major market participants and the rising cost of healthcare in the region

Cell Cryopreservation Market Segmentation

Grand view research has segmented the global cell cryopreservation market based on product, application, end-use, and region:

Cell Cryopreservation Product Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Freezing Media

  • Ethylene Glycol

  • Dimethyl Sulfoxide

  • Glycerol

  • Others

• Equipment

  • Freezers

  • Incubators

  • Liquid Nitrogen Supply Tanks

• Consumables

  • Cryogenic Vials

  • Cryogenic Tubes

  • Cooler Boxes/Containers

  • Others

Cell Cryopreservation Application Outlook (Revenue, USD Million, 2018 - 2030)

• Stem Cells

• Oocytes and Embryotic cells

• Sperm Cells

• Hepatocytes

• Others

Cell Cryopreservation End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical & Pharmaceutical Companies

• Research Institutes

• Biobanks

• IVF clinics

• Others

Cell Cryopreservation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Cell Cryopreservation Market

• Thermo Fisher Scientific Inc.

• Merck KGaA

• Sartorius AG

• PromoCell GmbH

• Lonza

• HiMedia Laboratories

• Creative Biolabs

• Corning Incorporated

• BioLife Solutions Inc.